U.S. FDA panel votes against expanded use of Amarin drug

[riky]

U.S. FDA panel votes against expanded use of Amarin drug

By Toni Clarke (Reuters) - Amarin Corporation Plc's triglyceride-lowering drug Vascepa should not be approved for use in a broader patient population until results from an additional study have been analyzed, an advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 9-2 against approval of the drug for patients who also take a cholesterol-lowering statin such as Pfizer Inc's Lipitor and are at high risk of coronary heart disease. ...

Source: You are not allowed to view links. Register or Login